Montelukast Aurovitas

Medicinal product

(Invented) name

Montelukast Aurovitas

Active substance (s)

Montelukastas

Strength

5 mg

Pharmaceutical form

kramtomosios tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R03DC03, Montelukast

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2026-06-19

Date of renewal

Documents

3480_Montelukast Aurovitas 5 mg_PL.docx

3480_Montelukast Aurovitas 5 mg_PZ.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Montelukastas	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
121370	107478	1107478	lizdinė plokštelė	N28		Receptinis	LT/L/26/3480/001	Netiekiama	-	2026-12-01	No	-	-	Download

Stadijos

Data	Stadija
2026-06-19	Registruotas